Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
EyePoint Pharmaceuticals logo — Delivering Innovation to the Eye™ NOW HIRING!

EyePoint Pharmaceuticals

Delivering Innovation to the Eye™ NOW HIRING!

Founded 1987 190 employees Post-IPO Equity Total: $653.80M Biotechnology, Health Care +1

General Information

Company Name EyePoint Pharmaceuticals
Founded Year 1987
Founders / Decision Makers
Team member Team member Team member
Employees 190
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with EyePoint Pharmaceuticals. To contact EyePoint Pharmaceuticals, visit eyepointpharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does EyePoint Pharmaceuticals compare?

A PDF of EyePoint Pharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting EyePoint Pharmaceuticals soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About EyePoint Pharmaceuticals

EyePoint Pharmaceuticals (Nasdaq: EYPT) is a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders. The Company's pipeline leverages its proprietary Durasert® technology for sustained intraocular drug delivery including EYP-1901, a potential six-month intravitreal anti-VEGF treatment initially targeting wet age-related macular degeneration. Durasert’s proven intravitreal drug delivery platform has been safely administered to thousands of patients' eyes across four U.S. FDA-approved products, including YUTIQ® for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye, which is currently marketed by the Company. EyePoint Pharmaceuticals is headquartered in Watertown, Massachusetts.

Funding Rounds & Investors (10)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $215.90M -
05 Dec 2023
Post IPO Debt $45.00M 1
Silicon Valley Bank
09 Mar 2022
Post IPO Equity $115.40M -
16 Nov 2021
Post IPO Equity $115.00M -
04 Feb 2021
Post IPO Equity $15.70M 1
Ocumension Therapeutics
03 Jan 2021
Debt Financing $60.00M 1
CRG
CRG
13 Feb 2019
Post IPO Equity $29.00M 1
Essex Woodlands Healthcare Partners
02 Oct 2018
Post IPO Equity $7.00M 1
RA Capital Management
RA Capital Management
13 Mar 2014
Post IPO Equity $10.80M -
19 Jul 2013
Post IPO Equity $40.00M -
18 Jul 2012

EyePoint Pharmaceuticals Alternatives & Competitors

EyePoint Pharmaceuticals vs
Kodiak Sciences
Kodiak Sciences United States

We are a clinical stage biopharma company bringing new science to prevent and treat high prevalence...

Post-IPO Equity
108 employees
Biotechnology, Health Care
EyePoint Pharmaceuticals vs
Acer Therapeutics Inc.
Acer Therapeutics Inc. United States

Focused on the acquisition, development & commercialization of therapies for serious rare and life-t...

Post-IPO Debt
16 employees
Biotechnology, Health and Wellness

FAQ About EyePoint Pharmaceuticals

Delivering Innovation to the Eye™ NOW HIRING!
EyePoint Pharmaceuticals was founded in 1987.
EyePoint Pharmaceuticals operates in Biotechnology, Health Care and Pharmaceutical.
EyePoint Pharmaceuticals has approximately 190 employees.
EyePoint Pharmaceuticals has completed 10 funding rounds, raising a total of $653.80M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to EyePoint Pharmaceuticals include Kodiak Sciences, Acer Therapeutics Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
EyePoint Pharmaceuticals and Kodiak Sciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for EyePoint Pharmaceuticals, https://bouncewatch.com/company/eyepoint-pharmaceuticals, updated 20 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout